{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T21:13:08Z","timestamp":1772831588055,"version":"3.50.1"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2015,12,9]],"date-time":"2015-12-09T00:00:00Z","timestamp":1449619200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Science and Technology Major Project of Gansu Province","award":["1203NKDA027"],"award-info":[{"award-number":["1203NKDA027"]}]},{"name":"Science and Technology Project Program of Lanzhou","award":["2011-1-61"],"award-info":[{"award-number":["2011-1-61"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Virol"],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1007\/s00705-015-2704-8","type":"journal-article","created":{"date-parts":[[2015,12,9]],"date-time":"2015-12-09T15:29:31Z","timestamp":1449674971000},"page":"685-691","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Immunoenhancement with flagellin as an adjuvant to whole-killed rabies vaccine in mice"],"prefix":"10.1007","volume":"161","author":[{"given":"Xing-xing","family":"Xiao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ji-xing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiao-lin","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiang-ping","family":"Yin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,12,9]]},"reference":[{"key":"2704_CR1","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.cell.2006.02.015","volume":"124","author":"S Akira","year":"2006","unstructured":"Akira S, Uematsu S, Takeuchi O (2006) Pathogen recognition and innate immunity. Cell 124:783\u2013801","journal-title":"Cell"},{"key":"2704_CR2","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1016\/j.vaccine.2012.12.059","volume":"31","author":"MR Asadi Karam","year":"2013","unstructured":"Asadi Karam MR, Oloomi M, Mahdavi M, Habibi M, Bouzari S (2013) Vaccination with recombinant FimH fused with flagellin enhances cellular and humoral immunity against urinary tract infection in mice. Vaccine 31:1210\u20131216","journal-title":"Vaccine"},{"key":"2704_CR3","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1586\/14760584.6.6.939","volume":"6","author":"T Ben-Yedidia","year":"2007","unstructured":"Ben-Yedidia T, Arnon R (2007) Epitope-based vaccine against influenza. Expert Rev Vaccines 6:939\u2013948","journal-title":"Expert Rev Vaccines"},{"key":"2704_CR4","doi-asserted-by":"crossref","first-page":"2986","DOI":"10.1128\/JVI.02886-12","volume":"87","author":"Z Chen","year":"2013","unstructured":"Chen Z, Zhou M, Gao X, Zhang G, Ren G, Gnanadurai CW, Fu ZF, He B (2013) A novel rabies vaccine based on a recombinant parainfluenza virus 5 expressing rabies virus glycoprotein. J Virol 87:2986\u20132993","journal-title":"J Virol"},{"key":"2704_CR5","doi-asserted-by":"crossref","first-page":"2810","DOI":"10.1128\/IAI.72.5.2810-2816.2004","volume":"72","author":"C Cuadros","year":"2004","unstructured":"Cuadros C, Lopez-Hernandez FJ, Dominguez AL, McClelland M, Lustgarten J (2004) Flagellin fusion proteins as adjuvants or vaccines induce specific immune responses. Infect Immun 72:2810\u20132816","journal-title":"Infect Immun"},{"key":"2704_CR6","first-page":"45","volume":"292","author":"B Dietzschold","year":"2005","unstructured":"Dietzschold B, Schnell M, Koprowski H (2005) Pathogenesis of rabies. Curr Top Microbiol Immunol 292:45\u201356","journal-title":"Curr Top Microbiol Immunol"},{"key":"2704_CR7","doi-asserted-by":"crossref","first-page":"e515","DOI":"10.1371\/journal.pntd.0000515","volume":"3","author":"HC Ertl","year":"2009","unstructured":"Ertl HC (2009) Novel vaccines to human rabies. PLoS Negl Trop Dis 3:e515","journal-title":"PLoS Negl Trop Dis"},{"key":"2704_CR8","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.2105\/AJPH.56.12.2106","volume":"56","author":"P Fenje","year":"1966","unstructured":"Fenje P, Pinteric L (1966) Potentiation of tissue culture rabies vaccine by adjuvants. Am J Public Health Nations Health 56:2106\u20132113","journal-title":"Am J Public Health Nations Health"},{"key":"2704_CR9","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.1128\/IAI.01074-12","volume":"81","author":"C Ghose","year":"2013","unstructured":"Ghose C, Verhagen JM, Chen X, Yu J, Huang Y, Chenesseau O, Kelly CP, Ho DD (2013) Toll-like receptor 5-dependent immunogenicity and protective efficacy of a recombinant fusion protein vaccine containing the nontoxic domains of Clostridium difficile toxins A and B and Salmonella enterica serovar typhimurium flagellin in a mouse model of Clostridium difficile disease. Infect Immun 81:2190\u20132196","journal-title":"Infect Immun"},{"key":"2704_CR10","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1038\/35074106","volume":"410","author":"F Hayashi","year":"2001","unstructured":"Hayashi F, Smith KD, Ozinsky A, Hawn TR, Yi EC, Goodlett DR, Eng JK, Akira S, Underhill DM, Aderem A (2001) The innate immune response to bacterial flagellin is mediated by Toll-like receptor 5. Nature 410:1099\u20131103","journal-title":"Nature"},{"key":"2704_CR11","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1128\/IAI.74.2.1113-1120.2006","volume":"74","author":"AN Honko","year":"2006","unstructured":"Honko AN, Sriranganathan N, Lees CJ, Mizel SB (2006) Flagellin is an effective adjuvant for immunization against lethal respiratory challenge with Yersinia pestis. Infect Immun 74:1113\u20131120","journal-title":"Infect Immun"},{"key":"2704_CR12","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/j.vaccine.2006.08.013","volume":"25","author":"JW Huleatt","year":"2007","unstructured":"Huleatt JW, Jacobs AR, Tang J, Desai P, Kopp EB, Huang Y, Song L, Nakaar V, Powell TJ (2007) Vaccination with recombinant fusion proteins incorporating Toll-like receptor ligands induces rapid cellular and humoral immunity. Vaccine 25:763\u2013775","journal-title":"Vaccine"},{"key":"2704_CR13","doi-asserted-by":"crossref","first-page":"6833","DOI":"10.1016\/j.vaccine.2012.09.013","volume":"30","author":"G Liu","year":"2012","unstructured":"Liu G, Song L, Reiserova L, Trivedi U, Li H, Liu X, Noah D, Hou F, Weaver B, Tussey L (2012) Flagellin-HA vaccines protect ferrets and mice against H5N1 highly pathogenic avian influenza virus (HPAIV) infections. Vaccine 30:6833\u20136838","journal-title":"Vaccine"},{"key":"2704_CR14","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.ijbiomac.2012.01.035","volume":"50","author":"Y Liu","year":"2012","unstructured":"Liu Y, Zhang S, Zhang F, Hu R (2012) Adjuvant activity of Chinese herbal polysaccharides in inactivated veterinary rabies vaccines. Int J Biol Macromol 50:598\u2013602","journal-title":"Int J Biol Macromol"},{"key":"2704_CR15","first-page":"1","volume":"57","author":"SE Manning","year":"2008","unstructured":"Manning SE, Rupprecht CE, Fishbein D, Hanlon CA, Lumlertdacha B, Guerra M, Meltzer MI, Dhankhar P, Vaidya SA, Jenkins SR, Sun B, Hull HF, Advisory Committee on Immunization Practices Centers for Disease C, Prevention, (2008) Human rabies prevention\u2014United States, 2008: recommendations of the Advisory Committee on Immunization Practices. MMWR Recomm Rep 57:1\u201328","journal-title":"MMWR Recomm Rep"},{"key":"2704_CR16","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/S1201-9712(00)90114-0","volume":"4","author":"L Martinez","year":"2000","unstructured":"Martinez L (2000) Global infectious disease surveillance. Int J Infect Dis 4:222\u2013228","journal-title":"Int J Infect Dis"},{"key":"2704_CR17","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1086\/517613","volume":"195","author":"WF McDonald","year":"2007","unstructured":"McDonald WF, Huleatt JW, Foellmer HG, Hewitt D, Tang J, Desai P, Price A, Jacobs A, Takahashi VN, Huang Y, Nakaar V, Alexopoulou L, Fikrig E, Powell TJ (2007) A West Nile virus recombinant protein vaccine that coactivates innate and adaptive immunity. J Infect Dis 195:1607\u20131617","journal-title":"J Infect Dis"},{"key":"2704_CR18","doi-asserted-by":"crossref","first-page":"3914","DOI":"10.4049\/jimmunol.169.7.3914","volume":"169","author":"SJ McSorley","year":"2002","unstructured":"McSorley SJ, Ehst BD, Yu Y, Gewirtz AT (2002) Bacterial flagellin is an effective adjuvant for CD4+ T cells in vivo. J Immunol 169:3914\u20133919","journal-title":"J Immunol"},{"key":"2704_CR19","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.vaccine.2011.10.095","volume":"30","author":"CF Shen","year":"2012","unstructured":"Shen CF, Lanthier S, Jacob D, Montes J, Beath A, Beresford A, Kamen A (2012) Process optimization and scale-up for production of rabies vaccine live adenovirus vector (AdRG1.3). Vaccine 30:300\u2013306","journal-title":"Vaccine"},{"key":"2704_CR20","first-page":"113","volume":"4","author":"E Shen","year":"2007","unstructured":"Shen E, Li L, Li L, Feng L, Lu L, Yao Z, Lin H, Wu C (2007) PIKA as an adjuvant enhances specific humoral and cellular immune responses following the vaccination of mice with HBsAg plus PIKA. Cell Mol Immunol 4:113\u2013120","journal-title":"Cell Mol Immunol"},{"key":"2704_CR21","doi-asserted-by":"crossref","first-page":"4103","DOI":"10.1016\/j.vaccine.2009.07.058","volume":"28","author":"I Skountzou","year":"2010","unstructured":"Skountzou I, Martin Mdel P, Wang B, Ye L, Koutsonanos D, Weldon W, Jacob J, Compans RW (2010) Salmonella flagellins are potent adjuvants for intranasally administered whole inactivated influenza vaccine. Vaccine 28:4103\u20134112","journal-title":"Vaccine"},{"key":"2704_CR22","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1038\/ni1011","volume":"4","author":"KD Smith","year":"2003","unstructured":"Smith KD, Andersen-Nissen E, Hayashi F, Strobe K, Bergman MA, Barrett SL, Cookson BT, Aderem A (2003) Toll-like receptor 5 recognizes a conserved site on flagellin required for protofilament formation and bacterial motility. Nat Immunol 4:1247\u20131253","journal-title":"Nat Immunol"},{"key":"2704_CR23","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.it.2005.11.005","volume":"27","author":"D Duin van","year":"2006","unstructured":"van Duin D, Medzhitov R, Shaw AC (2006) Triggering TLR signaling in vaccination. Trends Immunol 27:49\u201355","journal-title":"Trends Immunol"},{"key":"2704_CR24","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1128\/CVI.00153-12","volume":"19","author":"BZ Wang","year":"2012","unstructured":"Wang BZ, Gill HS, Kang SM, Wang L, Wang YC, Vassilieva EV, Compans RW (2012) Enhanced influenza virus-like particle vaccines containing the extracellular domain of matrix protein 2 and a Toll-like receptor ligand. Clin Vaccine Immunol 19:1119\u20131125","journal-title":"Clin Vaccine Immunol"},{"key":"2704_CR25","unstructured":"WHO (2005) First report of the WHO Expert Committee on Rabies. Technical Report Series 931. WHO, Geneva"},{"key":"2704_CR26","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1126\/science.322276","volume":"196","author":"J Zieg","year":"1977","unstructured":"Zieg J, Silverman M, Hilmen M, Simon M (1977) Recombinational switch for gene expression. Science 196:170\u2013172","journal-title":"Science"}],"container-title":["Archives of Virology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00705-015-2704-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00705-015-2704-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00705-015-2704-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T04:59:00Z","timestamp":1559105940000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00705-015-2704-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12,9]]},"references-count":26,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,3]]}},"alternative-id":["2704"],"URL":"https:\/\/doi.org\/10.1007\/s00705-015-2704-8","relation":{},"ISSN":["0304-8608","1432-8798"],"issn-type":[{"value":"0304-8608","type":"print"},{"value":"1432-8798","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,12,9]]}}}